121 related articles for article (PubMed ID: 9099325)
1. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children.
Bhattacharya K; Bhattacharya MK; Dutta D; Dutta S; Deb M; Deb A; Das KP; Koley H; Nair GB
Acta Paediatr; 1997 Mar; 86(3):319-20. PubMed ID: 9099325
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of norfloxacin for shigellosis.
Bhattacharya SK; Bhattacharya MK; Dutta P; Sen D; Rasaily R; Moitra A; Pal SC
Am J Trop Med Hyg; 1991 Dec; 45(6):683-7. PubMed ID: 1763794
[TBL] [Abstract][Full Text] [Related]
4. An unusual hallucination with norfloxacin.
Rataboli PV; D'Souza RS; Dhume VG
J Assoc Physicians India; 1996 Jul; 44(7):504. PubMed ID: 9282621
[No Abstract] [Full Text] [Related]
5. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.
Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK
Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805
[TBL] [Abstract][Full Text] [Related]
6. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children.
Islam MR; Alam AN; Hossain MS; Mahalanabis D; Hye HK
J Trop Pediatr; 1994 Dec; 40(6):320-5. PubMed ID: 7853434
[TBL] [Abstract][Full Text] [Related]
8. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
Salam MA; Dhar U; Khan WA; Bennish ML
Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
[TBL] [Abstract][Full Text] [Related]
9. Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis.
Salam MA; Bennish ML
J Pediatr; 1988 Nov; 113(5):901-7. PubMed ID: 3054035
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
Moolasart P; Eampokalap B; Ratanasrithong M
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):764-9. PubMed ID: 10928373
[TBL] [Abstract][Full Text] [Related]
11. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt.
Bassily S; Hyams KC; el-Masry NA; Farid Z; Cross E; Bourgeois AL; Ayad E; Hibbs RG
Am J Trop Med Hyg; 1994 Aug; 51(2):219-23. PubMed ID: 8074256
[TBL] [Abstract][Full Text] [Related]
12. [Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases].
Wang XF; Jiang SC; Wei YL
Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):482-4, 511. PubMed ID: 2086018
[TBL] [Abstract][Full Text] [Related]
13. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
[TBL] [Abstract][Full Text] [Related]
14. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
Khan WA; Seas C; Dhar U; Salam MA; Bennish ML
Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
[TBL] [Abstract][Full Text] [Related]
16. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial.
Grangé JD; Roulot D; Pelletier G; Pariente EA; Denis J; Ink O; Blanc P; Richardet JP; Vinel JP; Delisle F; Fischer D; Flahault A; Amiot X
J Hepatol; 1998 Sep; 29(3):430-6. PubMed ID: 9764990
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics in the management of shigellosis in children: what role for the quinolones?
Fontaine O
Rev Infect Dis; 1989; 11 Suppl 5():S1145-50. PubMed ID: 2672246
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of current shigellosis treatment.
Bhattacharya SK; Sur D
Expert Opin Pharmacother; 2003 Aug; 4(8):1315-20. PubMed ID: 12877639
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial.
Pimentel FL; Dolgner A; Guimarães J; Quintas M; Mário-Reis J
J Chemother; 1998 Apr; 10(2):122-7. PubMed ID: 9603637
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of clinical efficacy of norfloxacin (NFLX) and pipemidic acid (PPA) in the treatment of infectious enteritis by a double-blind method. The Japan Research Committee of Norfloxacin Research Group Enteritis].
Aoki T; Shimizu N; Tomizawa I; Takizawa Y; Matsubara Y; Seo T; Sagara H; Tagawa K; Masuda G; Negishi M
Kansenshogaku Zasshi; 1987 Jul; 61(7):830-48. PubMed ID: 3123572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
